|
|
Prepublished online as a Blood First Edition Paper on December 27, 2002; DOI 10.1182/blood-2002-07-2331.
Previous Article | Table of Contents | Next Article 
Blood, 15 April 2003, Vol. 101, No. 8, pp. 3042-3048
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Direct binding of Nur77/NAK-1 to the plasminogen activator
inhibitor 1 (PAI-1) promoter regulates TNF -induced PAI-1
expression
Florian Gruber,
Peter Hufnagl,
Renate Hofer-Warbinek,
Johannes A. Schmid,
Johannes M. Breuss,
Renate Huber-Beckmann,
Markus Lucerna,
Nikolina Papac,
Hanna Harant,
Ivan Lindley,
Rainer de
Martin, and
Bernd R. Binder
From the Department of Vascular Biology and Thrombosis
Research, University of Vienna, Austria; Roche Diagnostics
GmbH, Vienna, Austria; Novartis Research Institute,
Vienna, Austria; Bio Molecular Therapeutics
(BMT) Research, Vienna, Austria; and Ludwig
Boltzmann Institute for Applied Cancer Research, Vienna,
Austria.
Plasminogen activator inhibitor 1 (PAI-1) is the main
fibrinolysis inhibitor, and high plasma levels are associated with an increased risk for vascular diseases. Inflammatory cytokines regulate PAI-1 through a hitherto unclear mechanism. Using reporter gene analysis, we could identify a region in the PAI-1 promoter that contributes to basal expression as well as to tumor necrosis factor (TNF ) induction of PAI-1 in endothelial cells. Using this
region as bait in a genetic screen, we could identify Nur77 (NAK-1,
TR3, NR4A1) as an inducible DNA-binding protein that binds specifically to the PAI-1 promoter. Nur77 drives transcription of PAI-1 through direct binding to an NGFI-B responsive element (NBRE),
indicating monomeric binding and a ligand-independent mechanism. Nur77,
itself, is transcriptionally up-regulated by TNF . High expression
levels of Nur77 and its colocalization with PAI-1 in atherosclerotic tissues indicate that the described mechanism for PAI-1 regulation may
also be operative in vivo.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Platzer, S. Richter, D. Kneidinger, D. Waltenberger, M. Woisetschlager, and H. Strobl
Aryl Hydrocarbon Receptor Activation Inhibits In Vitro Differentiation of Human Monocytes and Langerhans Dendritic Cells
J. Immunol.,
July 1, 2009;
183(1):
66 - 74.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, A. E Dear, L. B Knudsen, and R. W Simpson
A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules
J. Endocrinol.,
April 1, 2009;
201(1):
59 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. You, Y.-Y. Jiang, S. Chen, G. Yan, and J. Sun
The Orphan Nuclear Receptor Nur77 Suppresses Endothelial Cell Activation Through Induction of I{kappa}B{alpha} Expression
Circ. Res.,
March 27, 2009;
104(6):
742 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Prager, J. Mihaly, P. M. Brunner, Y. Koshelnick, G. Hoyer-Hansen, and B. R. Binder
Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein
Blood,
February 5, 2009;
113(6):
1383 - 1390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. B. Schiller, A. Szekeres, B. R. Binder, H. Stockinger, and V. Leksa
Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor Limits Cell Invasion by Controlling {alpha}V{beta}3 Integrin Expression and Proteolytic Processing of Urokinase-type Plasminogen Activator Receptor
Mol. Biol. Cell,
February 1, 2009;
20(3):
745 - 756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Manna, M. T. Dyson, Y. Jo, and D. M. Stocco
Role of Dosage-Sensitive Sex Reversal, Adrenal Hypoplasia Congenita, Critical Region on the X Chromosome, Gene 1 in Protein Kinase A- and Protein Kinase C-Mediated Regulation of the Steroidogenic Acute Regulatory Protein Expression in Mouse Leydig Tumor Cells: Mechanism of Action
Endocrinology,
January 1, 2009;
150(1):
187 - 199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Abtin, L. Eckhart, M. Mildner, F. Gruber, J.-M. Schroder, and E. Tschachler
Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli
FASEB J,
July 1, 2008;
22(7):
2168 - 2176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Liu, Y. Hu, R. W Simpson, and A. E Dear
Glucagon-like peptide-1 attenuates tumour necrosis factor-{alpha}-mediated induction of plasmogen activator inhibitor-1 expression
J. Endocrinol.,
January 1, 2008;
196(1):
57 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Mix, M. G. Attur, H. Al-Mussawir, S. B. Abramson, C. E. Brinckerhoff, and E. P. Murphy
Transcriptional Repression of Matrix Metalloproteinase Gene Expression by the Orphan Nuclear Receptor NURR1 in Cartilage
J. Biol. Chem.,
March 30, 2007;
282(13):
9492 - 9504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Inoue, M. Kobayashi, K. Yano, M. Miura, A. Izumi, C. Mataki, T. Doi, T. Hamakubo, P. C. Reid, D. A. Hume, et al.
Histone Deacetylase Inhibitor Reduces Monocyte Adhesion to Endothelium Through the Suppression of Vascular Cell Adhesion Molecule-1 Expression
Arterioscler Thromb Vasc Biol,
December 1, 2006;
26(12):
2652 - 2659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, L. Yin, and M. A. Lazar
The Orphan Nuclear Receptor Rev-erb{alpha} Regulates Circadian Expression of Plasminogen Activator Inhibitor Type 1
J. Biol. Chem.,
November 10, 2006;
281(45):
33842 - 33848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lucerna, J. Pomyje, D. Mechtcheriakova, A. Kadl, F. Gruber, M. Bilban, Y. Sobanov, G. Schabbauer, J. Breuss, O. Wagner, et al.
Sustained Expression of Early Growth Response Protein-1 Blocks Angiogenesis and Tumor Growth.
Cancer Res.,
July 1, 2006;
66(13):
6708 - 6713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pei, A. Castrillo, and P. Tontonoz
Regulation of Macrophage Inflammatory Gene Expression by the Orphan Nuclear Receptor Nur77
Mol. Endocrinol.,
April 1, 2006;
20(4):
786 - 794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Pei, A. Castrillo, M. Chen, A. Hoffmann, and P. Tontonoz
Induction of NR4A Orphan Nuclear Receptor Expression in Macrophages in Response to Inflammatory Stimuli
J. Biol. Chem.,
August 12, 2005;
280(32):
29256 - 29262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu, C. J. Lee, T. T. Lee, K. Gernert, T. J. Murphy, and J. R. Hepler
Differential Effects of Gq{alpha}, G14{alpha}, and G15{alpha} on Vascular Smooth Muscle Cell Survival and Gene Expression Profiles
Mol. Pharmacol.,
June 1, 2005;
67(6):
2102 - 2114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Martinez-Gonzalez and L. Badimon
The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells
Cardiovasc Res,
February 15, 2005;
65(3):
609 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kudo, E. Nakayama, S. Suzuki, M. Akiyama, and S. Shibata
Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver
Am J Physiol Endocrinol Metab,
October 1, 2004;
287(4):
E644 - E651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Shin, B.-H. Lee, M. G. Yeo, S.-H. Oh, J.-D. Park, K.-K. Park, J.-H. Chung, C.-K. Moon, and M.-O. Lee
Induction of orphan nuclear receptor Nur77 gene expression and its role in cadmium-induced apoptosis in lung
Carcinogenesis,
August 1, 2004;
25(8):
1467 - 1475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Luyendyk, W. B. Mattes, L. D. Burgoon, T. R. Zacharewski, J. F. Maddox, G. N. Cosma, P. E. Ganey, and R. A. Roth
Gene Expression Analysis Points to Hemostasis in Livers of Rats Cotreated with Lipopolysaccharide and Ranitidine
Toxicol. Sci.,
July 1, 2004;
80(1):
203 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mayer, M. Bilban, V. Kurtev, F. Gruber, O. Wagner, B. R. Binder, and R. de Martin
Deciphering Regulatory Patterns of Inflammatory Gene Expression From Interleukin-1--Stimulated Human Endothelial Cells
Arterioscler Thromb Vasc Biol,
July 1, 2004;
24(7):
1192 - 1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hou, M. Eren, C. A. Painter, J. W. Covington, J. D. Dixon, J. A. Schoenhard, and D. E. Vaughan
Tumor Necrosis Factor {alpha} Activates the Human Plasminogen Activator Inhibitor-1 Gene through a Distal Nuclear Factor {kappa}B Site
J. Biol. Chem.,
April 30, 2004;
279(18):
18127 - 18136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Liu, H. Jia, D. I. R. Holmes, A. Stannard, and I. Zachary
Vascular Endothelial Growth Factor-Regulated Gene Expression in Endothelial Cells: KDR-Mediated Induction of Egr3 and the Related Nuclear Receptors Nur77, Nurr1, and Nor1
Arterioscler Thromb Vasc Biol,
November 1, 2003;
23(11):
2002 - 2007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Arkenbout, M. van Bragt, E. Eldering, C. van Bree, J. M. Grimbergen, P. H.A. Quax, H. Pannekoek, and C. J.M. de Vries
TR3 Orphan Receptor Is Expressed in Vascular Endothelial Cells and Mediates Cell Cycle Arrest
Arterioscler Thromb Vasc Biol,
September 1, 2003;
23(9):
1535 - 1540.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|